期刊文献+

重组人p53腺病毒联合顺铂对肺腺癌A549细胞基因表达的影响 被引量:5

Effect of Recombinant Human Adenovirus p53 Combined with Cisplatin on the Expression of Human Lung Adenocarcinoma A549 Cell Gene
下载PDF
导出
摘要 目的研究重组人p53腺病毒(rAd-p53)联合顺铂对肺腺癌A549细胞基因表达的影响,探讨rAd-p53增强顺铂对A549细胞抑制作用的机制。方法通过基因芯片检测技术,比较rAd-p53联合顺铂与单独顺铂处理后的肺腺癌A549细胞肿瘤相关基因表达的差异,采用SAM软件对结果进行分析。结果 rAd-p53联合顺铂与单独顺铂处理的A549细胞比较,15个基因表达显著上调,28个基因表达显著下调。结论 rAd-p53增强顺铂对A549细胞的抑制作用与导入外源性p53基因后,p53基因表达上调并引起调控细胞周期、细胞增殖、细胞凋亡的一系列基因的表达变化。 Objective To explore the effect of recombinant human adenovirus p53(rAd-p53)com-bined with cisplatin on the expression of human lung adenocarcinoma A549 cells.Methods Human lung ade-nocarcinoma A549 cells were treated with rAd-p53 combined with cisplatin(combination group)or with cispl-atin alone(cisplatin group).The expressions of the cell genes were compared between these two groups and the results were analyzed by SAM software.Result A total of 43 differential genes were found,15 of which were up-regulated and 28 were down-regulated.Conclusion Following introduction of rAd-p53,many genes regulating cell cycle,proliferation and apoptosis expresses up or down which significantly enhance chemosensi-tivity and killing efficiency of cisplatin on human lung adenocarcinoma A549 cells.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2010年第4期383-388,480,共7页 Acta Academiae Medicinae Sinicae
关键词 重组人P53腺病毒 肺腺癌A549细胞株 基因芯片 recombinant human adenovirus p53 lung adenocarcinoma A549 cell line microarray
  • 相关文献

参考文献3

二级参考文献79

  • 1王朝霞,陆彬彬,王腾,德伟,束永前.重组人p53腺病毒注射液(今又生)对人肺腺癌细胞生长及化疗敏感性研究[J].中国肺癌杂志,2006,9(2):127-131. 被引量:16
  • 2[1]Mauri DN, Ebner R, Montgomery RI, et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 1998; 8:21-30
  • 3[2]Harrop JA, McDonnell PC, Brigham-Burke M, et al. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem 1998; 273:27548-56.
  • 4[3]Rooney IA, Butrovich KD, Glass AA, et al. The lymphotoxinbeta receptor is necessary and sufficient for LIGHT- mediated apoptosis of tumor cells. J Biol Chem 2000; 275:14307-15.
  • 5[4]Yang D, Zhai Y, Zhang M. LIGHT, a new member of the TNF superfamily. J Biol Regul Homeost Agents 2002; 16:206-10.
  • 6[5]Zhai Y, Guo R, Hsu TL, et al. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest 1998; 102:1142-51.
  • 7[6]Hikichi Y, Matsui H, Tsuji I, et al. LIGHT, a member of the TNF superfamily, induces morphological changes and delays proliferation in the human rhabdomyosarcoma cell line RD. Biochem Biophys Res Commun 2001; 289:670-7.
  • 8[7]Matsui H, Hikichi Y, Tsuji I, Yamada T, Shintani Y. LIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosis. J Biol Chem,2002; 277:50054-61.
  • 9[8]Tamada K, Shimozaki K, Chapoval AI, et al. LIGHT, a TNFlike molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol2000; 164:4105-10.
  • 10[9]Tamada K, Shimozaki K, Chapoval AI, et al. Modulation of Tcell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat Med2000; 6:283-9.

共引文献14

同被引文献44

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部